Allogeneic Hematopoietic Cell Transplant For Bone Marrow Failure or Myelodysplastic Syndrome in Dyskeratosis Congenita/Telomere Biology Disorders: Single-Center, Single-Arm, Open-Label Trial of Reduced-Intensity Conditioning Without Radiation
Marketa Dimitrov(University of Minnesota Medical Center), Christen L. Ebens(University of Minnesota), Svatava Merkle(Cincinnati Children's Hospital Medical Center), Shernan G. Holtan(University of Minnesota), Gregory M. Vercellotti(University of Minnesota Medical Center), Jakub Tolar(University of Minnesota System), Stephanie A. Terezakis(Johns Hopkins University), Meera Srikanthan(University of Minnesota Medical Center), Roy L. Kao(University of Minnesota), Qing Cao(Hebei Normal University), Rebecca Tryon(University of Minnesota)
Cited by 5
Related Papers
Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins
|Blood|2012|743
Carbon Monoxide Generated by Heme Oxygenase-1 Suppresses the Rejection of Mouse-to-Rat Cardiac Transplants
|The Journal of Immunology|2001|462
Toward High-Performance Digital Logic Technology with Carbon Nanotubes
|ACS Nano|2014|307